APO Research
Talk to an analyst

APO RESEARCH · REPORT

Endocrine Therapy Medication

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Endocrine Therapy Medication Industry Growth and Trends Forecast to 2032

27 December 2025120 pages

Choose your research edition.

Industry ResearchEndocrine Therapy Medication Industry Research Report 2026150 pages · $2,950 USDIndustry Growth & TrendsGlobal Endocrine Therapy Medication Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Endocrine Therapy Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Endocrine Therapy Medication Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Endocrine Therapy Medication Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Endocrine Therapy Medication market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Endocrine Therapy Medication is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Endocrine Therapy Medication is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Endocrine Therapy Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Endocrine Therapy Medication include Chongqing Laimi Pharmaceutical Co., Ltd., Zhongpeptide Biochemical Co., Ltd., Zhejiang Haizhou Pharmaceutical Co., Ltd., Zhejiang Haizheng Pharmaceutical Co., Ltd., Changchun Jinsai Pharmaceutical Co., Ltd., Yangtze River Pharmaceutical Group Co., Ltd., Shenzhen Hanyu Pharmaceutical Co., Ltd., Shanghai Lizhu Pharmaceutical Co., Ltd. and Shanghai Fudan Fuhua Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Endocrine Therapy Medication market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Endocrine Therapy Medication market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Endocrine Therapy Medication market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Endocrine Therapy Medication.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Endocrine Therapy Medication market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Endocrine Therapy Medication Market by Company

Chongqing Laimi Pharmaceutical Co., Ltd.

Zhongpeptide Biochemical Co., Ltd.

Zhejiang Haizhou Pharmaceutical Co., Ltd.

Zhejiang Haizheng Pharmaceutical Co., Ltd.

Changchun Jinsai Pharmaceutical Co., Ltd.

Yangtze River Pharmaceutical Group Co., Ltd.

Shenzhen Hanyu Pharmaceutical Co., Ltd.

Shanghai Lizhu Pharmaceutical Co., Ltd.

Shanghai Fudan Fuhua Pharmaceutical Co., Ltd.

Shanghai Zhaohui Pharmaceutical Co., Ltd.

Maanshan Fengyuan Pharmaceutical Co., Ltd.

Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.

Jiangsu Aosaikang Pharmaceutical Co., Ltd.

Good Doctor Pharmaceutical Group Co., Ltd.

Dandong Yichuang Pharmaceutical Co., Ltd.

Chengdu Tiantaishan Pharmaceutical Co., Ltd.

Beijing Bornte Pharmaceutical Co., Ltd.

Teva

Pfizer

Janssen Biotech

Eli Lilly and Company

Dr. Reddy's

Cougar Biotechnology, Inc.

AstraZeneca

Endocrine Therapy Medication Segment by Type

Hormones and Related Drugs

Hormone Antagonists and Related Drugs

Endocrine Therapy Medication Segment by Application

Hospital

Clinic

Other

Endocrine Therapy Medication Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endocrine Therapy Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Endocrine Therapy Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endocrine Therapy Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Endocrine Therapy Medication manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Endocrine Therapy Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Hormones and Related Drugs Table 2. Major Company of Hormone Antagonists and Related Drugs Table 3. Global Endocrine Therapy Medication Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Endocrine Therapy Medication Sales by Type (2021-2026) & (K Units) Table 5. Global Endocrine Therapy Medication Sales Market Share in Volume by Type (2021-2026) Table 6. Global Endocrine Therapy Medication Sales by Type (2021-2026) & (US$ Million) Table 7. Global Endocrine Therapy Medication Sales Market Share in Value by Type (2021-2026) Table 8. Global Endocrine Therapy Medication Price by Type (2021-2026) & (US$/Unit) Table 9. Global Endocrine Therapy Medication Sales by Type (2027-2032) & (K Units) Table 10. Global Endocrine Therapy Medication Sales Market Share in Volume by Type (2027-2032) Table 11. Global Endocrine Therapy Medication Sales by Type (2027-2032) & (US$ Million) Table 12. Global Endocrine Therapy Medication Sales Market Share in Value by Type (2027-2032) Table 13. Global Endocrine Therapy Medication Price by Type (2027-2032) & (US$/Unit) Table 14. North America Endocrine Therapy Medication Sales by Type (2021-2026) & (K Units) Table 15. North America Endocrine Therapy Medication Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Endocrine Therapy Medication Sales by Type (2021-2026) & (K Units) Table 17. Europe Endocrine Therapy Medication Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Endocrine Therapy Medication Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Endocrine Therapy Medication Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Endocrine Therapy Medication Sales by Type (2021-2026) & (K Units) Table 21. Latin America Endocrine Therapy Medication Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Endocrine Therapy Medication Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Endocrine Therapy Medication Sales by Type (2021-2026) & (US$ Million) Table 24. Endocrine Therapy Medication Industry Trends Table 25. Endocrine Therapy Medication Industry Drivers Table 26. Endocrine Therapy Medication Industry Opportunities and Challenges Table 27. Endocrine Therapy Medication Industry Restraints Table 28. Global Endocrine Therapy Medication Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Endocrine Therapy Medication Revenue Market Share by Company (2021-2026) Table 30. Global Endocrine Therapy Medication Sales by Company (2021-2026) & (K Units) Table 31. Global Endocrine Therapy Medication Sales Share by Company (2021-2026) Table 32. Global Endocrine Therapy Medication Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Endocrine Therapy Medication Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Endocrine Therapy Medication Major Company Production Sites and Headquarters Table 35. Global Endocrine Therapy Medication Company, Product Type & Application Table 36. Global Endocrine Therapy Medication Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Endocrine Therapy Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Endocrine Therapy Medication Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Endocrine Therapy Medication Sales by Region (2021-2026) & (K Units) Table 41. Global Endocrine Therapy Medication Sales Market Share in Volume by Region (2021-2026) Table 42. Global Endocrine Therapy Medication Sales by Region (2021-2026) & (US$ Million) Table 43. Global Endocrine Therapy Medication Sales Market Share in Value by Region (2021-2026) Table 44. Global Endocrine Therapy Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Endocrine Therapy Medication Sales by Region (2027-2032) & (K Units) Table 46. Global Endocrine Therapy Medication Sales Market Share in Volume by Region (2027-2032) Table 47. Global Endocrine Therapy Medication Sales by Region (2027-2032) & (US$ Million) Table 48. Global Endocrine Therapy Medication Sales Market Share in Value by Region (2027-2032) Table 49. Global Endocrine Therapy Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Endocrine Therapy Medication Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Endocrine Therapy Medication Sales by Application (2021-2026) & (K Units) Table 52. Global Endocrine Therapy Medication Sales Market Share in Volume by Application (2021-2026) Table 53. Global Endocrine Therapy Medication Sales by Application (2021-2026) & (US$ Million) Table 54. Global Endocrine Therapy Medication Sales Market Share in Value by Application (2021-2026) Table 55. Global Endocrine Therapy Medication Price by Application (2021-2026) & (US$/Unit) Table 56. Global Endocrine Therapy Medication Sales by Application (2027-2032) & (K Units) Table 57. Global Endocrine Therapy Medication Sales Market Share in Volume by Application (2027-2032) Table 58. Global Endocrine Therapy Medication Sales by Application (2027-2032) & (US$ Million) Table 59. Global Endocrine Therapy Medication Sales Market Share in Value by Application (2027-2032) Table 60. Global Endocrine Therapy Medication Price by Application (2027-2032) & (US$/Unit) Table 61. North America Endocrine Therapy Medication Sales by Application (2021-2026) & (K Units) Table 62. North America Endocrine Therapy Medication Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Endocrine Therapy Medication Sales by Application (2021-2026) & (K Units) Table 64. Europe Endocrine Therapy Medication Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Endocrine Therapy Medication Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Endocrine Therapy Medication Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Endocrine Therapy Medication Sales by Application (2021-2026) & (K Units) Table 68. Latin America Endocrine Therapy Medication Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Endocrine Therapy Medication Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Endocrine Therapy Medication Sales by Application (2021-2026) & (US$ Million) Table 71. Chongqing Laimi Pharmaceutical Co., Ltd. Company Information Table 72. Chongqing Laimi Pharmaceutical Co., Ltd. Business Overview Table 73. Chongqing Laimi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Chongqing Laimi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 75. Chongqing Laimi Pharmaceutical Co., Ltd. Recent Development Table 76. Zhongpeptide Biochemical Co., Ltd. Company Information Table 77. Zhongpeptide Biochemical Co., Ltd. Business Overview Table 78. Zhongpeptide Biochemical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Zhongpeptide Biochemical Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 80. Zhongpeptide Biochemical Co., Ltd. Recent Development Table 81. Zhejiang Haizhou Pharmaceutical Co., Ltd. Company Information Table 82. Zhejiang Haizhou Pharmaceutical Co., Ltd. Business Overview Table 83. Zhejiang Haizhou Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Zhejiang Haizhou Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 85. Zhejiang Haizhou Pharmaceutical Co., Ltd. Recent Development Table 86. Zhejiang Haizheng Pharmaceutical Co., Ltd. Company Information Table 87. Zhejiang Haizheng Pharmaceutical Co., Ltd. Business Overview Table 88. Zhejiang Haizheng Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Zhejiang Haizheng Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 90. Zhejiang Haizheng Pharmaceutical Co., Ltd. Recent Development Table 91. Changchun Jinsai Pharmaceutical Co., Ltd. Company Information Table 92. Changchun Jinsai Pharmaceutical Co., Ltd. Business Overview Table 93. Changchun Jinsai Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Changchun Jinsai Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 95. Changchun Jinsai Pharmaceutical Co., Ltd. Recent Development Table 96. Yangtze River Pharmaceutical Group Co., Ltd. Company Information Table 97. Yangtze River Pharmaceutical Group Co., Ltd. Business Overview Table 98. Yangtze River Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Yangtze River Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 100. Yangtze River Pharmaceutical Group Co., Ltd. Recent Development Table 101. Shenzhen Hanyu Pharmaceutical Co., Ltd. Company Information Table 102. Shenzhen Hanyu Pharmaceutical Co., Ltd. Business Overview Table 103. Shenzhen Hanyu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Shenzhen Hanyu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 105. Shenzhen Hanyu Pharmaceutical Co., Ltd. Recent Development Table 106. Shanghai Lizhu Pharmaceutical Co., Ltd. Company Information Table 107. Shanghai Lizhu Pharmaceutical Co., Ltd. Business Overview Table 108. Shanghai Lizhu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Shanghai Lizhu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 110. Shanghai Lizhu Pharmaceutical Co., Ltd. Recent Development Table 111. Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Company Information Table 112. Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Business Overview Table 113. Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 115. Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Recent Development Table 116. Shanghai Zhaohui Pharmaceutical Co., Ltd. Company Information Table 117. Shanghai Zhaohui Pharmaceutical Co., Ltd. Business Overview Table 118. Shanghai Zhaohui Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Shanghai Zhaohui Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 120. Shanghai Zhaohui Pharmaceutical Co., Ltd. Recent Development Table 121. Maanshan Fengyuan Pharmaceutical Co., Ltd. Company Information Table 122. Maanshan Fengyuan Pharmaceutical Co., Ltd. Business Overview Table 123. Maanshan Fengyuan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Maanshan Fengyuan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 125. Maanshan Fengyuan Pharmaceutical Co., Ltd. Recent Development Table 126. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Company Information Table 127. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Business Overview Table 128. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 130. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Recent Development Table 131. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Company Information Table 132. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Business Overview Table 133. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 135. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Recent Development Table 136. Good Doctor Pharmaceutical Group Co., Ltd. Company Information Table 137. Good Doctor Pharmaceutical Group Co., Ltd. Business Overview Table 138. Good Doctor Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Good Doctor Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 140. Good Doctor Pharmaceutical Group Co., Ltd. Recent Development Table 141. Dandong Yichuang Pharmaceutical Co., Ltd. Company Information Table 142. Dandong Yichuang Pharmaceutical Co., Ltd. Business Overview Table 143. Dandong Yichuang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Dandong Yichuang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 145. Dandong Yichuang Pharmaceutical Co., Ltd. Recent Development Table 146. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Company Information Table 147. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Business Overview Table 148. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 150. Chengdu Tiantaishan Pharmaceutical Co., Ltd. Recent Development Table 151. Beijing Bornte Pharmaceutical Co., Ltd. Company Information Table 152. Beijing Bornte Pharmaceutical Co., Ltd. Business Overview Table 153. Beijing Bornte Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Beijing Bornte Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio Table 155. Beijing Bornte Pharmaceutical Co., Ltd. Recent Development Table 156. Teva Company Information Table 157. Teva Business Overview Table 158. Teva Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Teva Endocrine Therapy Medication Product Portfolio Table 160. Teva Recent Development Table 161. Pfizer Company Information Table 162. Pfizer Business Overview Table 163. Pfizer Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. Pfizer Endocrine Therapy Medication Product Portfolio Table 165. Pfizer Recent Development Table 166. Janssen Biotech Company Information Table 167. Janssen Biotech Business Overview Table 168. Janssen Biotech Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 169. Janssen Biotech Endocrine Therapy Medication Product Portfolio Table 170. Janssen Biotech Recent Development Table 171. Eli Lilly and Company Company Information Table 172. Eli Lilly and Company Business Overview Table 173. Eli Lilly and Company Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 174. Eli Lilly and Company Endocrine Therapy Medication Product Portfolio Table 175. Eli Lilly and Company Recent Development Table 176. Dr. Reddy's Company Information Table 177. Dr. Reddy's Business Overview Table 178. Dr. Reddy's Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 179. Dr. Reddy's Endocrine Therapy Medication Product Portfolio Table 180. Dr. Reddy's Recent Development Table 181. Cougar Biotechnology, Inc. Company Information Table 182. Cougar Biotechnology, Inc. Business Overview Table 183. Cougar Biotechnology, Inc. Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 184. Cougar Biotechnology, Inc. Endocrine Therapy Medication Product Portfolio Table 185. Cougar Biotechnology, Inc. Recent Development Table 186. AstraZeneca Company Information Table 187. AstraZeneca Business Overview Table 188. AstraZeneca Endocrine Therapy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 189. AstraZeneca Endocrine Therapy Medication Product Portfolio Table 190. AstraZeneca Recent Development Table 191. North America Endocrine Therapy Medication Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 192. North America Endocrine Therapy Medication Sales by Country (2021-2026) & (K Units) Table 193. North America Endocrine Therapy Medication Sales Market Share by Country (2021-2026) Table 194. North America Endocrine Therapy Medication Sales Forecast by Country (2027-2032) & (K Units) Table 195. North America Endocrine Therapy Medication Sales Market Share Forecast by Country (2027-2032) Table 196. North America Endocrine Therapy Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. North America Endocrine Therapy Medication Market Size by Country (2021-2026) & (US$ Million) Table 198. North America Endocrine Therapy Medication Market Share by Country (2021-2026) Table 199. North America Endocrine Therapy Medication Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. North America Endocrine Therapy Medication Market Share Forecast by Country (2027-2032) Table 201. Europe Endocrine Therapy Medication Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 202. Europe Endocrine Therapy Medication Sales by Country (2021-2026) & (K Units) Table 203. Europe Endocrine Therapy Medication Sales Market Share by Country (2021-2026) Table 204. Europe Endocrine Therapy Medication Sales Forecast by Country (2027-2032) & (K Units) Table 205. Europe Endocrine Therapy Medication Sales Market Share Forecast by Country (2027-2032) Table 206. Europe Endocrine Therapy Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 207. Europe Endocrine Therapy Medication Market Size by Country (2021-2026) & (US$ Million) Table 208. Europe Endocrine Therapy Medication Market Share by Country (2021-2026) Table 209. Europe Endocrine Therapy Medication Market Size Forecast by Country (2027-2032) & (US$ Million) Table 210. Europe Endocrine Therapy Medication Market Share Forecast by Country (2027-2032) Table 211. Asia-Pacific Endocrine Therapy Medication Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 212. Asia-Pacific Endocrine Therapy Medication Sales by Country (2021-2026) & (K Units) Table 213. Asia-Pacific Endocrine Therapy Medication Sales Market Share by Country (2021-2026) Table 214. Asia-Pacific Endocrine Therapy Medication Sales Forecast by Country (2027-2032) & (K Units) Table 215. Asia-Pacific Endocrine Therapy Medication Sales Market Share Forecast by Country (2027-2032) Table 216. Asia-Pacific Endocrine Therapy Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 217. Asia-Pacific Endocrine Therapy Medication Market Size by Country (2021-2026) & (US$ Million) Table 218. Asia-Pacific Endocrine Therapy Medication Market Share by Country (2021-2026) Table 219. Asia-Pacific Endocrine Therapy Medication Market Size Forecast by Country (2027-2032) & (US$ Million) Table 220. Asia-Pacific Endocrine Therapy Medication Market Share Forecast by Country (2027-2032) Table 221. Latin America Endocrine Therapy Medication Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 222. Latin America Endocrine Therapy Medication Sales by Country (2021-2026) & (K Units) Table 223. Latin America Endocrine Therapy Medication Sales Market Share by Country (2021-2026) Table 224. Latin America Endocrine Therapy Medication Sales Forecast by Country (2027-2032) & (K Units) Table 225. Latin America Endocrine Therapy Medication Sales Market Share Forecast by Country (2027-2032) Table 226. Latin America Endocrine Therapy Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 227. Latin America Endocrine Therapy Medication Market Size by Country (2021-2026) & (US$ Million) Table 228. Latin America Endocrine Therapy Medication Market Share by Country (2021-2026) Table 229. Latin America Endocrine Therapy Medication Market Size Forecast by Country (2027-2032) & (US$ Million) Table 230. Latin America Endocrine Therapy Medication Market Share Forecast by Country (2027-2032) Table 231. Middle East and Africa Endocrine Therapy Medication Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 232. Middle East and Africa Endocrine Therapy Medication Sales by Country (2021-2026) & (K Units) Table 233. Middle East and Africa Endocrine Therapy Medication Sales Market Share by Country (2021-2026) Table 234. Middle East and Africa Endocrine Therapy Medication Sales Forecast by Country (2027-2032) & (K Units) Table 235. Middle East and Africa Endocrine Therapy Medication Sales Market Share Forecast by Country (2027-2032) Table 236. Middle East and Africa Endocrine Therapy Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 237. Middle East and Africa Endocrine Therapy Medication Market Size by Country (2021-2026) & (US$ Million) Table 238. Middle East and Africa Endocrine Therapy Medication Market Share by Country (2021-2026) Table 239. Middle East and Africa Endocrine Therapy Medication Market Size Forecast by Country (2027-2032) & (US$ Million) Table 240. Middle East and Africa Endocrine Therapy Medication Market Share Forecast by Country (2027-2032) Table 241. Key Raw Materials Table 242. Raw Materials Key Suppliers Table 243. Endocrine Therapy Medication Distributors List Table 244. Endocrine Therapy Medication Customers List Table 245. Research Programs/Design for This Report Table 246. Authors List of This Report Table 247. Secondary Sources Table 248. Primary Sources List of Figures Figure 1. Endocrine Therapy Medication Image Figure 2. Global Endocrine Therapy Medication Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Endocrine Therapy Medication Market Size (2021-2032) & (US$ Million) Figure 4. Global Endocrine Therapy Medication Sales (2021-2032) & (K Units) Figure 5. Hormones and Related Drugs Image Figure 6. Global Hormones and Related Drugs Sales YoY Growth (2021-2032) & (K Units) Figure 7. Hormone Antagonists and Related Drugs Image Figure 8. Global Hormone Antagonists and Related Drugs Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Endocrine Therapy Medication Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Endocrine Therapy Medication Market Share by Type 2025 VS 2032 Figure 11. North America Endocrine Therapy Medication Sales Market Share in Volume by Type in 2025 Figure 12. North America Endocrine Therapy Medication Sales Market Share in Value by Type in 2025 Figure 13. Europe Endocrine Therapy Medication Sales Market Share in Volume by Type in 2025 Figure 14. Europe Endocrine Therapy Medication Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Endocrine Therapy Medication Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Endocrine Therapy Medication Sales Market Share in Value by Type in 2025 Figure 17. Latin America Endocrine Therapy Medication Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Endocrine Therapy Medication Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Endocrine Therapy Medication Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Endocrine Therapy Medication Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Endocrine Therapy Medication Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Endocrine Therapy Medication Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Endocrine Therapy Medication Market Share by Application 2025 VS 2032 Figure 31. North America Endocrine Therapy Medication Sales Market Share in Volume by Application in 2025 Figure 32. North America Endocrine Therapy Medication Sales Market Share in Value by Application in 2025 Figure 33. Europe Endocrine Therapy Medication Sales Market Share in Volume by Application in 2025 Figure 34. Europe Endocrine Therapy Medication Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Endocrine Therapy Medication Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Endocrine Therapy Medication Sales Market Share in Value by Application in 2025 Figure 37. Latin America Endocrine Therapy Medication Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Endocrine Therapy Medication Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Endocrine Therapy Medication Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Endocrine Therapy Medication Sales Market Share in Value by Application in 2025 Figure 41. North America Endocrine Therapy Medication Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Endocrine Therapy Medication Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Endocrine Therapy Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Endocrine Therapy Medication Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Endocrine Therapy Medication Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Endocrine Therapy Medication Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Endocrine Therapy Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Endocrine Therapy Medication Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Endocrine Therapy Medication Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Endocrine Therapy Medication Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Endocrine Therapy Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Endocrine Therapy Medication Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Endocrine Therapy Medication Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Endocrine Therapy Medication Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Endocrine Therapy Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Endocrine Therapy Medication Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Endocrine Therapy Medication Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Endocrine Therapy Medication Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Endocrine Therapy Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Endocrine Therapy Medication Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Endocrine Therapy Medication Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Endocrine Therapy Medication Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Hormones and Related Drugs
  • Hormone Antagonists and Related Drugs
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Chongqing Laimi Pharmaceutical Co., Ltd.
  • Zhongpeptide Biochemical Co., Ltd.
  • Zhejiang Haizhou Pharmaceutical Co., Ltd.
  • Zhejiang Haizheng Pharmaceutical Co., Ltd.
  • Changchun Jinsai Pharmaceutical Co., Ltd.
  • Yangtze River Pharmaceutical Group Co., Ltd.
  • Shenzhen Hanyu Pharmaceutical Co., Ltd.
  • Shanghai Lizhu Pharmaceutical Co., Ltd.
  • Shanghai Fudan Fuhua Pharmaceutical Co., Ltd.
  • Shanghai Zhaohui Pharmaceutical Co., Ltd.
  • Maanshan Fengyuan Pharmaceutical Co., Ltd.
  • Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.
  • Jiangsu Aosaikang Pharmaceutical Co., Ltd.
  • Good Doctor Pharmaceutical Group Co., Ltd.
  • Dandong Yichuang Pharmaceutical Co., Ltd.
  • Chengdu Tiantaishan Pharmaceutical Co., Ltd.
  • Beijing Bornte Pharmaceutical Co., Ltd.
  • Teva
  • Pfizer
  • Janssen Biotech
  • Eli Lilly and Company
  • Dr. Reddy's
  • Cougar Biotechnology, Inc.
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Endocrine Therapy Medication Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Endocrine Therapy Medication Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Endocrine Therapy Medication Market by Type
  6. 1.3.1 Hormones and Related Drugs
  7. 1.3.2 Hormone Antagonists and Related Drugs
  8. 1.4 Global Endocrine Therapy Medication Market Size by Type
  9. 1.4.1 Global Endocrine Therapy Medication Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Endocrine Therapy Medication Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Endocrine Therapy Medication Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Endocrine Therapy Medication Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Endocrine Therapy Medication Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Endocrine Therapy Medication Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Endocrine Therapy Medication Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Endocrine Therapy Medication Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Endocrine Therapy Medication Industry Trends
  2. 2.2 Endocrine Therapy Medication Industry Drivers
  3. 2.3 Endocrine Therapy Medication Industry Opportunities and Challenges
  4. 2.4 Endocrine Therapy Medication Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Endocrine Therapy Medication Revenue (2021-2026)
  2. 3.2 Global Top Players by Endocrine Therapy Medication Sales (2021-2026)
  3. 3.3 Global Top Players by Endocrine Therapy Medication Price (2021-2026)
  4. 3.4 Global Endocrine Therapy Medication Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Endocrine Therapy Medication Major Company Production Sites & Headquarters
  6. 3.6 Global Endocrine Therapy Medication Company, Product Type & Application
  7. 3.7 Global Endocrine Therapy Medication Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Endocrine Therapy Medication Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Endocrine Therapy Medication Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Endocrine Therapy Medication Tier 1, Tier 2, and Tier 3
4 Endocrine Therapy Medication Regional Status and Outlook
  1. 4.1 Global Endocrine Therapy Medication Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Endocrine Therapy Medication Historic Market Size by Region
  3. 4.2.1 Global Endocrine Therapy Medication Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Endocrine Therapy Medication Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Endocrine Therapy Medication Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Endocrine Therapy Medication Forecasted Market Size by Region
  7. 4.3.1 Global Endocrine Therapy Medication Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Endocrine Therapy Medication Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Endocrine Therapy Medication Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Endocrine Therapy Medication by Application
  1. 5.1 Endocrine Therapy Medication Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Endocrine Therapy Medication Market Size by Application
  6. 5.2.1 Global Endocrine Therapy Medication Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Endocrine Therapy Medication Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Endocrine Therapy Medication Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Endocrine Therapy Medication Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Endocrine Therapy Medication Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Endocrine Therapy Medication Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Endocrine Therapy Medication Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Endocrine Therapy Medication Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chongqing Laimi Pharmaceutical Co., Ltd.
  2. 6.1.1 Chongqing Laimi Pharmaceutical Co., Ltd. Company Information
  3. 6.1.2 Chongqing Laimi Pharmaceutical Co., Ltd. Business Overview
  4. 6.1.3 Chongqing Laimi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chongqing Laimi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
  6. 6.1.5 Chongqing Laimi Pharmaceutical Co., Ltd. Recent Developments
  7. 6.2 Zhongpeptide Biochemical Co., Ltd.
  8. 6.2.1 Zhongpeptide Biochemical Co., Ltd. Company Information
  9. 6.2.2 Zhongpeptide Biochemical Co., Ltd. Business Overview
  10. 6.2.3 Zhongpeptide Biochemical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Zhongpeptide Biochemical Co., Ltd. Endocrine Therapy Medication Product Portfolio
  12. 6.2.5 Zhongpeptide Biochemical Co., Ltd. Recent Developments
  13. 6.3 Zhejiang Haizhou Pharmaceutical Co., Ltd.
  14. 6.3.1 Zhejiang Haizhou Pharmaceutical Co., Ltd. Company Information
  15. 6.3.2 Zhejiang Haizhou Pharmaceutical Co., Ltd. Business Overview
  16. 6.3.3 Zhejiang Haizhou Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Zhejiang Haizhou Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
  18. 6.3.5 Zhejiang Haizhou Pharmaceutical Co., Ltd. Recent Developments
  19. 6.4 Zhejiang Haizheng Pharmaceutical Co., Ltd.
  20. 6.4.1 Zhejiang Haizheng Pharmaceutical Co., Ltd. Company Information
  21. 6.4.2 Zhejiang Haizheng Pharmaceutical Co., Ltd. Business Overview
  22. 6.4.3 Zhejiang Haizheng Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Zhejiang Haizheng Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
  24. 6.4.5 Zhejiang Haizheng Pharmaceutical Co., Ltd. Recent Developments
  25. 6.5 Changchun Jinsai Pharmaceutical Co., Ltd.
  26. 6.5.1 Changchun Jinsai Pharmaceutical Co., Ltd. Company Information
  27. 6.5.2 Changchun Jinsai Pharmaceutical Co., Ltd. Business Overview
  28. 6.5.3 Changchun Jinsai Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Changchun Jinsai Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
  30. 6.5.5 Changchun Jinsai Pharmaceutical Co., Ltd. Recent Developments
  31. 6.6 Yangtze River Pharmaceutical Group Co., Ltd.
  32. 6.6.1 Yangtze River Pharmaceutical Group Co., Ltd. Company Information
  33. 6.6.2 Yangtze River Pharmaceutical Group Co., Ltd. Business Overview
  34. 6.6.3 Yangtze River Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Yangtze River Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Product Portfolio
  36. 6.6.5 Yangtze River Pharmaceutical Group Co., Ltd. Recent Developments
  37. 6.7 Shenzhen Hanyu Pharmaceutical Co., Ltd.
  38. 6.7.1 Shenzhen Hanyu Pharmaceutical Co., Ltd. Company Information
  39. 6.7.2 Shenzhen Hanyu Pharmaceutical Co., Ltd. Business Overview
  40. 6.7.3 Shenzhen Hanyu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Shenzhen Hanyu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
  42. 6.7.5 Shenzhen Hanyu Pharmaceutical Co., Ltd. Recent Developments
  43. 6.8 Shanghai Lizhu Pharmaceutical Co., Ltd.
  44. 6.8.1 Shanghai Lizhu Pharmaceutical Co., Ltd. Company Information
  45. 6.8.2 Shanghai Lizhu Pharmaceutical Co., Ltd. Business Overview
  46. 6.8.3 Shanghai Lizhu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Shanghai Lizhu Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
  48. 6.8.5 Shanghai Lizhu Pharmaceutical Co., Ltd. Recent Developments
  49. 6.9 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd.
  50. 6.9.1 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Company Information
  51. 6.9.2 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Business Overview
  52. 6.9.3 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
  54. 6.9.5 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Recent Developments
  55. 6.10 Shanghai Zhaohui Pharmaceutical Co., Ltd.
  56. 6.10.1 Shanghai Zhaohui Pharmaceutical Co., Ltd. Company Information
  57. 6.10.2 Shanghai Zhaohui Pharmaceutical Co., Ltd. Business Overview
  58. 6.10.3 Shanghai Zhaohui Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Shanghai Zhaohui Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
  60. 6.10.5 Shanghai Zhaohui Pharmaceutical Co., Ltd. Recent Developments
  61. 6.11 Maanshan Fengyuan Pharmaceutical Co., Ltd.
  62. 6.11.1 Maanshan Fengyuan Pharmaceutical Co., Ltd. Company Information
  63. 6.11.2 Maanshan Fengyuan Pharmaceutical Co., Ltd. Business Overview
  64. 6.11.3 Maanshan Fengyuan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Maanshan Fengyuan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
  66. 6.11.5 Maanshan Fengyuan Pharmaceutical Co., Ltd. Recent Developments
  67. 6.12 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.
  68. 6.12.1 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Company Information
  69. 6.12.2 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Business Overview
  70. 6.12.3 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
  72. 6.12.5 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Recent Developments
  73. 6.13 Jiangsu Aosaikang Pharmaceutical Co., Ltd.
  74. 6.13.1 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Company Information
  75. 6.13.2 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Business Overview
  76. 6.13.3 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
  78. 6.13.5 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Recent Developments
  79. 6.14 Good Doctor Pharmaceutical Group Co., Ltd.
  80. 6.14.1 Good Doctor Pharmaceutical Group Co., Ltd. Company Information
  81. 6.14.2 Good Doctor Pharmaceutical Group Co., Ltd. Business Overview
  82. 6.14.3 Good Doctor Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Good Doctor Pharmaceutical Group Co., Ltd. Endocrine Therapy Medication Product Portfolio
  84. 6.14.5 Good Doctor Pharmaceutical Group Co., Ltd. Recent Developments
  85. 6.15 Dandong Yichuang Pharmaceutical Co., Ltd.
  86. 6.15.1 Dandong Yichuang Pharmaceutical Co., Ltd. Company Information
  87. 6.15.2 Dandong Yichuang Pharmaceutical Co., Ltd. Business Overview
  88. 6.15.3 Dandong Yichuang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Dandong Yichuang Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
  90. 6.15.5 Dandong Yichuang Pharmaceutical Co., Ltd. Recent Developments
  91. 6.16 Chengdu Tiantaishan Pharmaceutical Co., Ltd.
  92. 6.16.1 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Company Information
  93. 6.16.2 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Business Overview
  94. 6.16.3 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
  96. 6.16.5 Chengdu Tiantaishan Pharmaceutical Co., Ltd. Recent Developments
  97. 6.17 Beijing Bornte Pharmaceutical Co., Ltd.
  98. 6.17.1 Beijing Bornte Pharmaceutical Co., Ltd. Company Information
  99. 6.17.2 Beijing Bornte Pharmaceutical Co., Ltd. Business Overview
  100. 6.17.3 Beijing Bornte Pharmaceutical Co., Ltd. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Beijing Bornte Pharmaceutical Co., Ltd. Endocrine Therapy Medication Product Portfolio
  102. 6.17.5 Beijing Bornte Pharmaceutical Co., Ltd. Recent Developments
  103. 6.18 Teva
  104. 6.18.1 Teva Company Information
  105. 6.18.2 Teva Business Overview
  106. 6.18.3 Teva Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Teva Endocrine Therapy Medication Product Portfolio
  108. 6.18.5 Teva Recent Developments
  109. 6.19 Pfizer
  110. 6.19.1 Pfizer Company Information
  111. 6.19.2 Pfizer Business Overview
  112. 6.19.3 Pfizer Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Pfizer Endocrine Therapy Medication Product Portfolio
  114. 6.19.5 Pfizer Recent Developments
  115. 6.20 Janssen Biotech
  116. 6.20.1 Janssen Biotech Company Information
  117. 6.20.2 Janssen Biotech Business Overview
  118. 6.20.3 Janssen Biotech Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Janssen Biotech Endocrine Therapy Medication Product Portfolio
  120. 6.20.5 Janssen Biotech Recent Developments
  121. 6.21 Eli Lilly and Company
  122. 6.21.1 Eli Lilly and Company Company Information
  123. 6.21.2 Eli Lilly and Company Business Overview
  124. 6.21.3 Eli Lilly and Company Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Eli Lilly and Company Endocrine Therapy Medication Product Portfolio
  126. 6.21.5 Eli Lilly and Company Recent Developments
  127. 6.22 Dr. Reddy's
  128. 6.22.1 Dr. Reddy's Company Information
  129. 6.22.2 Dr. Reddy's Business Overview
  130. 6.22.3 Dr. Reddy's Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Dr. Reddy's Endocrine Therapy Medication Product Portfolio
  132. 6.22.5 Dr. Reddy's Recent Developments
  133. 6.23 Cougar Biotechnology, Inc.
  134. 6.23.1 Cougar Biotechnology, Inc. Company Information
  135. 6.23.2 Cougar Biotechnology, Inc. Business Overview
  136. 6.23.3 Cougar Biotechnology, Inc. Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Cougar Biotechnology, Inc. Endocrine Therapy Medication Product Portfolio
  138. 6.23.5 Cougar Biotechnology, Inc. Recent Developments
  139. 6.24 AstraZeneca
  140. 6.24.1 AstraZeneca Company Information
  141. 6.24.2 AstraZeneca Business Overview
  142. 6.24.3 AstraZeneca Endocrine Therapy Medication Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 AstraZeneca Endocrine Therapy Medication Product Portfolio
  144. 6.24.5 AstraZeneca Recent Developments
7 North America by Country
  1. 7.1 North America Endocrine Therapy Medication Sales by Country
  2. 7.1.1 North America Endocrine Therapy Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Endocrine Therapy Medication Sales by Country (2021-2026)
  4. 7.1.3 North America Endocrine Therapy Medication Sales Forecast by Country (2027-2032)
  5. 7.2 North America Endocrine Therapy Medication Market Size by Country
  6. 7.2.1 North America Endocrine Therapy Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Endocrine Therapy Medication Market Size by Country (2021-2026)
  8. 7.2.3 North America Endocrine Therapy Medication Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Endocrine Therapy Medication Sales by Country
  2. 8.1.1 Europe Endocrine Therapy Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Endocrine Therapy Medication Sales by Country (2021-2026)
  4. 8.1.3 Europe Endocrine Therapy Medication Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Endocrine Therapy Medication Market Size by Country
  6. 8.2.1 Europe Endocrine Therapy Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Endocrine Therapy Medication Market Size by Country (2021-2026)
  8. 8.2.3 Europe Endocrine Therapy Medication Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Endocrine Therapy Medication Sales by Country
  2. 9.1.1 Asia-Pacific Endocrine Therapy Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Endocrine Therapy Medication Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Endocrine Therapy Medication Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Endocrine Therapy Medication Market Size by Country
  6. 9.2.1 Asia-Pacific Endocrine Therapy Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Endocrine Therapy Medication Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Endocrine Therapy Medication Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Endocrine Therapy Medication Sales by Country
  2. 10.1.1 South America Endocrine Therapy Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Endocrine Therapy Medication Sales by Country (2021-2026)
  4. 10.1.3 South America Endocrine Therapy Medication Sales Forecast by Country (2027-2032)
  5. 10.2 South America Endocrine Therapy Medication Market Size by Country
  6. 10.2.1 South America Endocrine Therapy Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Endocrine Therapy Medication Market Size by Country (2021-2026)
  8. 10.2.3 South America Endocrine Therapy Medication Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Endocrine Therapy Medication Sales by Country
  2. 11.1.1 Middle East and Africa Endocrine Therapy Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Endocrine Therapy Medication Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Endocrine Therapy Medication Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Endocrine Therapy Medication Market Size by Country
  6. 11.2.1 Middle East and Africa Endocrine Therapy Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Endocrine Therapy Medication Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Endocrine Therapy Medication Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Endocrine Therapy Medication Value Chain Analysis
  2. 12.1.1 Endocrine Therapy Medication Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Endocrine Therapy Medication Production Mode & Process
  7. 12.2 Endocrine Therapy Medication Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Endocrine Therapy Medication Distributors
  10. 12.2.3 Endocrine Therapy Medication Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst